JMP Securities Downgrades Savient Pharmaceuticals (SVNT) to Market Underperform
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
JMP Securities downgraded Savient Pharmaceuticals (NASDAQ: SVNT) from Market Perform to Market Underperform with a new price target of $1.50.
For an analyst ratings summary and ratings history on Savient Pharmaceuticals click here. For more ratings news on Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $2.98 yesterday.
For an analyst ratings summary and ratings history on Savient Pharmaceuticals click here. For more ratings news on Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $2.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Temple & Webster Group Ltd (TPW:AU) to Sector Perform
- CLSA Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Underperform (4)
- CLSA Downgrades Tata Consultancy Services Ltd. (TCS:IN) to Hold (3)
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
